Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer

BACKGROUND: Survival benefit of neoadjuvant chemotherapy (NAC) for advanced gastric cancer (AGC) is a debatable issue. Studies have shown that the survival benefit of NAC is dependent on the pathological response to chemotherapy drugs. For those who achieve pathological complete response (pCR), NAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yong-He, Xiao, Jian, Chen, Xi-Jie, Wang, Hua-She, Liu, Dan, Xiang, Jun, Peng, Jun-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243641/
https://www.ncbi.nlm.nih.gov/pubmed/32476803
http://dx.doi.org/10.3748/wjg.v26.i19.2427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243641/
https://www.ncbi.nlm.nih.gov/pubmed/32476803
http://dx.doi.org/10.3748/wjg.v26.i19.2427

Ejemplares similares